New shot in the works makes GM food look like child’s play

You won’t believe what they’re putting GMOs in now!

I’ve been warning you for years about genetically modified (GMO) Frankenfoods that have been linked to everything from diabetes to cancer.

But now a company called Novavax has developed a GMO vaccine — and they’re saying it’s going to be the top-selling shot in history.

It’s supposed to treat respiratory syncytial virus (RSV), a common infection most of us catch during our lives that usually just causes a cough or sniffles. In babies and seniors, however, it can lead to pneumonia.

But this “breakthrough” shot is based on a very dangerous lie and comes with a history that left hospitalized and even dead children in its wake. And its little GMO secret could place it among the riskiest vaccines on the market today.

A frightening history — and futureA top Novavax exec is calling the company’s new, experimental RSV vaccine a “historic advance.” But when it comes to developing an RSV shot, the last thing any drug company should talk about is history.

Drug companies have avoided an RSV vaccine for years, because when one was first tested in the 1960s it left 80 percent of kids who got it hospitalized. Two even died.

And when you hear how Novavax made its new shot, I doubt you’re going to feel any safer.

You see, Novavax is trying to solve the problem with earlier vaccines by including a GMO virus in its shot. Just like with GMO foods, scientists have been warning for years that we don’t fully understand the long-term risks of these lab-created, gene-spliced vaccines.

But some of the early results are frightening. Two of the most dangerous vaccines on the market today — the hepatitis B vaccine and the HPV shot Gardasil — are also GMO. And they’ve been linked to paralysis, nervous system disorders, liver diseases, and even death.

One top vaccine scientist even warned in the Journal of Toxicology and Environmental Health Sciences that there’s simply no way to predict the “unintended events or the consequences” of genetically modifying vaccine viruses.

That’s one heck of a risk we’re being asked to take with a new RSV shot, especially when you consider these two facts:

#1: The vaccine doesn’t work very well. One study on volunteers over the age of 60 found that the shot failed 56 percent of the time. The pro-vax scientists claim that this dismal success rate is about on par with the worthless pneumonia shot Prevnar.

That’s some sales pitch, isn’t it? Our new junk isn’t any worse than the old junk we’re already selling you.

#2: The mainstream has been lying to us about RSV risks for years. The panic over RSV is lots of smoke and very little fire. For example, we’ve been told that thousands of American infants per year die from RSV infections — but a study last year from the University of Utah put the real number at about 40.

RSV can be serious. But the fact is, you have a greater chance of getting struck by lightning than dying from RSV. But that won’t stop Novavax — and eventually the CDC — from insisting that millions of us eventually get vaccinated anyway.

For its next logic-defying act, Novavax is trying to get pregnant women to sign up for a clinical trial to see if getting the RSV shot would benefit their kids.

And as you can imagine, that’s been a tough sell. Pregnant moms aren’t exactly lining up around the block to put their babies in harm’s way — especially courtesy of a highly experimental vaccine that doesn’t work very well, for a condition that’s usually not very serious.

“I don’t think I’d be comfortable with [it],” Pennsylvania mother Tiffany Weber recently told the Philadelphia Inquirer.

And why should she be? Novavax is asking us all to forget the RSV vaccine’s history — and the real data behind the shot and the illness it’s supposed to prevent.

I don’t think any of us should be too comfortable with that.

Sources:

“Novavax: Early study indicates its vaccine effective vs. RSV” Linda A. Johnson, August 10, 2015, AP, abcnews.go.com

“Vaccine for common cold virus may be available in 2 years” August 10, 2015, Newsmax Health, newsmax.com